Brief: Tianjin Teda Biomedical Engineering Says Zhongtai International Securities To Procure Placees
08/04/2025 16:39
April 8 (Reuters) - Tianjin TEDA Biomedical Engineering Co Ltd 8189.HK: ZHONGTAI INTERNATIONAL SECURITIES TO PROCURE TO NOT LESS THAN 6 PLACEES FOR CO PLACEES TO SUBSCRIBE FOR UP TO 103.5 MILLION PLACING SHARES AT HK$0.375 PER SHARE. Further company coverage: 8189.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Teda Biomedical Engineering Co
See all newsBrief: Tianjin Teda Biomedical Engineering Appoints Lynn Li As Joint CEO, Re-Designates Sun Li As Joint CEO
Brief: Tianjin Teda Biomedical Engineering Signs AI Healthcare Cooperation Agreement
Brief: Tianjin Teda Biomedical Engineering Says Unit Enters Strategic Cooperation
Brief: Tianjin Teda Biomedical Engineering Says Zhongtai International Securities To Procure Placees
Brief: Tianjin Teda Biomedical Engineering Says Re-Designation Of He Xin To Non-Executive Director